NEONC TECHNOLOGIES HOLDINGS, INC. Proceeds from Notes Payable
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) reported Proceeds from Notes Payable of $1.15 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-09.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2026-03-31
- NEONC TECHNOLOGIES HOLDINGS, INC. proceeds from notes payable for the quarter ending 2025-03-31 was $1.15M.
- NEONC TECHNOLOGIES HOLDINGS, INC. proceeds from notes payable for the quarter ending 2024-06-30 was $221.07K.
- NEONC TECHNOLOGIES HOLDINGS, INC. proceeds from notes payable for fiscal 2024 was $1.37M.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 12 month | Proceeds from Notes Payable 12 month as first filed |
|---|---|---|---|---|
| 2025-03-31 | $1.15M 10-Q · filed 2025-05-09 | |||
| 2024-12-31 | $1.37M 10-K · filed 2026-03-31 | $1.37M 10-Q · filed 2025-11-14 | ||
| 2024-06-30 | $221.07K 10-Q · filed 2025-08-18 | $1.37M 10-Q · filed 2025-08-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |